Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
An ethical case that was eventually decided in the US Supreme Court involves the right of patients to request an independent third-party review if their HMO refuses to authorize treatments or procedures deemed medically necessary.